Diaceutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 29, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	167	128	84	72	102	125
Market Cap Growth	13.42%	51.80%	17.69%	-29.68%	-18.50%	49.55%
Enterprise Value	156	109	65	50	74	92
Last Close Price	1.79	1.45	1.02	0.84	1.16	1.68
PE Ratio	-	-	-	87.95	152.85	426.74
PS Ratio	4.15	3.30	3.09	3.27	6.15	8.84
PB Ratio	3.84	2.66	1.80	1.50	2.11	2.79
P/TBV Ratio	6.53	4.34	2.87	2.32	3.06	3.59
P/FCF Ratio	14288.34	192.50	61.82	12.97	17150.06	967.52
P/OCF Ratio	1373.88	162.93	55.93	12.50	150.44	443.61
EV/Sales Ratio	3.93	2.81	2.39	2.29	4.46	6.50
EV/EBITDA Ratio	88.47	163.86	555.87	21.53	40.96	194.30
EV/EBIT Ratio	-	-	-	77.74	112.96	-
EV/FCF Ratio	13372.74	164.16	47.81	9.10	12425.86	711.89
Debt / Equity Ratio	0.03	0.03	0.03	0.03	0.04	0.00
Debt / EBITDA Ratio	0.74	1.50	4.73	0.60	1.00	0.28
Debt / FCF Ratio	113.40	1.92	1.02	0.27	312.20	1.02
Asset Turnover	0.77	0.68	0.50	0.42	0.32	0.39
Quick Ratio	3.66	3.66	6.11	8.07	11.24	11.33
Current Ratio	3.96	3.80	6.40	8.24	11.41	11.53
Return on Equity (ROE)	-4.00%	-4.22%	-4.19%	1.74%	1.39%	0.87%
Return on Assets (ROA)	-2.85%	-3.23%	-3.99%	0.77%	0.78%	-0.51%
Return on Invested Capital (ROIC)	-7.32%	-9.18%	-12.24%	2.47%	2.92%	-2.29%
Return on Capital Employed (ROCE)	-5.40%	-6.00%	-7.20%	1.30%	1.30%	-0.70%
Earnings Yield	-1.06%	-1.61%	-2.38%	1.14%	0.65%	0.23%
FCF Yield	0.01%	0.52%	1.62%	7.71%	0.01%	0.10%
Buyback Yield / Dilution	-0.19%	-0.27%	2.16%	-1.35%	-9.14%	-21.29%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.